Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia B Without Inhibitors”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Very early researchUnknownNCT06125756
What this trial is testing

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Who this might be right for
Hemophilia B Without Inhibitor
Affiliated Hospital of Guangdong Medical University 9
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Early research (Phase 1)Study completedNCT01439971
What this trial is testing

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Who this might be right for
Hemophilia A
Catalyst Biosciences 29
Large-scale testing (Phase 3)Active Not RecruitingNCT05135559
What this trial is testing

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Who this might be right for
Haemophilia A and B With and Without Inhibitors
Novo Nordisk A/S 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06569108
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Who this might be right for
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Suzhou Alphamab Co., Ltd. 125
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 189
Early research (Phase 1)Study completedNCT04072237
What this trial is testing

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Who this might be right for
Hemophilia AHemophilia BHemophilia A With Inhibitor+3 more
Catalyst Biosciences 11
Large-scale testing (Phase 3)Active Not RecruitingNCT04082429
What this trial is testing

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Who this might be right for
Haemophilia A Without InhibitorsHaemophilia B Without Inhibitors
Novo Nordisk A/S 156
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Very early researchUnknownNCT06119659
What this trial is testing

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Who this might be right for
Hemophilia B Without Inhibitor
Zhejiang University 9
Not applicableStudy completedNCT03741881
What this trial is testing

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

Who this might be right for
Haemophilia AHaemophilia A With InhibitorsHaemophilia B+1 more
Novo Nordisk A/S 231
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Testing effectiveness (Phase 2)Ended earlyNCT03597022
What this trial is testing

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Who this might be right for
Hemophilia A and B
Bayer 24
Not applicableActive Not RecruitingNCT07161687
What this trial is testing

Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.

Who this might be right for
Hemophilia A or B
Pfizer 50
Not applicableStudy completedNCT03596814
What this trial is testing

MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II

Who this might be right for
Hemophilia
Nantes University Hospital 2,072
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Not applicableWithdrawnNCT01541527
What this trial is testing

Non Neutralizing Antibodies: Prevalence and Characterization

Who this might be right for
Hemophilia A
University Hospital, Montpellier
Load More Results